Loading…

Victrex plcVCT.LCompetitor analysis, valuation and peers

United Kingdom · GBP·Materials›Chemicals: Major Diversified

UK maker of PEEK, a high-performance polymer used in aerospace, medical implants, automotive and electronics.

≈ The world's leading PEEK polymer producerMomentum leader 90
Mkt cap
$1.06B
US dollars, full cap
Free float
100%
of shares outstanding
$/day
$2.19M
20-day average traded
Fwd P/E
22.5×
forward earnings
ROIC−WACC
-2.7 pp
WACC 11.2%
Hurdle
+15 pp
Req g minus delivered
Next earnings
20 days
8 Dec 2026
Close · GBP£922.00
1D+1.6%
1W-1.4%
1M+1.3%
3M+13.6%
6M+45.7%
YTD+40.8%
1Y+53.7%
ATR %2.8%
52w lowhigh10.0% off high

What Victrex does

UK maker of PEEK, a high-performance polymer used in aerospace, medical implants, automotive and electronics.

Sells PEEK by weight to makers of components, with the medical grade sold through its Invibio unit, where each grade is qualified for implants over years and repeat orders follow. The company began as the ICI chemicals group's PEEK business before a 1990s buyout and listing.

In one line: The world's leading PEEK polymer producer.

Products and services

  • PEEK polymer resin
  • Invibio medical-grade PEEK (spinal implants)
  • Composite/film products

Customers

  • Aerospace component makers
  • Medical device makers (spinal implants)
  • Automotive & electronics OEMs

Where it sits in the supply chain

  • Materials/Chemicals
  • High-performance polymers
  • PEEK resin manufacturing

What could go right

  • Aerospace lightweighting demand
  • Medical implant adoption

What could go wrong

  • Aerospace/industrial cyclicality
  • Alternative-material substitution

Moat: wide (IP / patents, process know-how, scale). Global leader in patented PEEK manufacturing with decades of process know-how.

Headquarters: Thornton-Cleveleys, UK · Founded: 1993 · Employees: 1,169

Named competitors

Victrex at a glance

Size Victrex (VCT.L) is a United Kingdom Materials company (Chemicals: Major Diversified) with a market value of $1.06B, the 210th largest of 355 United Kingdom companies the cockpit tracks. Shares closed at £922.00 on 18 Nov 2026.

Performance Over six months the shares gained 45.7%, against -32.9% for the median peer and +0.1% for the United Kingdom market (cap-weighted) — 2nd highest of 21 in its peer set.

Growth Revenue fell 1.2% over the last twelve months (peer median +4.1%); the operating margin is 14.3% (peer median 10.2%).

Valuation It trades at 22.5× forward earnings against a peer median of 21.1× (4th most expensive of 14).

Price implies For today's price to make sense, revenue must grow about 17% a year for seven years (Req g). Recent delivered growth is +2%, so the hurdle is +15 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 2.7 points below its cost of capital (11.2% WACC).

Next results Next results expected around 8 Dec 2026 (exchange calendar; dates can move).

Relative performance

10015021 May 202621 Aug 202618 Nov 2026VCT.L 146Peer median 70
Six months, rebased to 100: Victrex against the median of its 20 peers (local-currency closes).

Victrex financials

Reported figures in GBP; fiscal year ends 2025-09-30. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue£294M£293M£291M£307M£341M
Revenue growth—+1%-5%-10%—
Gross profit£126M£128M£138M£168M£175M
EBITDA£66.9M£70.3M£90.4M£111M£121M
Net income-£19.7M£27.8M£17.2M£61.7M£76.2M
Free cash flow£48.0M£48.4M£50.3M£2.30M£34.5M
Capital expenditure£20.6M£21.8M£32.6M£38.5M£45.5M
Total debtn/a£49.0M£50.4M£50.2M£32.1M

Quarterly statements and history in the cockpit →

Victrex competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%7666300779JUBLINGREA6032006003282143704763603360603281RPELLXS0004203006416031810025854041688359300596014680VCT.L6-month return →1-month return →
Up and to the right = strong over both horizons. Victrex is the large dot.

Fundamentals: revenue growth against valuation

-20%-10%0%+10%0×50×100×300779JUBLINGREA21437047636033606032810004206031810025854041300596VCT.LRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Victrex is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%+40%-20%0%20%40%JUBLINGREA2143704763603360603281LXS3006410025854041301090VCT.LGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Victrex is the large dot.

Victrex competitors and peer comparison

Head to head with its named competitors (VCT.L vs EVK.DE vs CE)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Victrex VCT.L$1.06B+46%-1%14%22.5×16.7%
Evonik Industries EVK.DE$11.1B+27%+2%10%12.1×-5.6%
Celanese CE$5.29B-10%+1%9%7.8×6.0%

How Victrex compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Victrex against its 20 peers (data as of 18 Nov 2026)
MeasureVCT.LPeer medianRank in peer set
1-month return+1.3%-12.8%5th highest of 21
6-month return+45.7%-32.9%2nd highest of 21
Distance from 52-week high-10.0%-48.8%3rd highest of 21
Revenue growth (TTM)-1.2%+4.1%8th lowest of 21
Operating margin14.3%10.2%9th highest of 21
Forward P/E22.5×21.1×4th most expensive of 14
Growth the price implies (Req g, 7 yrs)16.7%7.1%5th most demanding of 12
Growth delivered (Del g)+1.9%+6.3%5th lowest of 12
Hurdle (Req g minus delivered)+14.7 pp-1.6 pp4th most demanding of 12
ROIC minus cost of capital-2.7 pp-1.8 pp10th lowest of 21
EV / EBITDA12.4×9.8×4th most expensive of 8
Net debt / EBITDA0.7×0.4×4th most indebted of 8

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Victrex VCT.LUnited Kingdom$1.06B+46%-1%14%22.5×16.7%+1.9%
Metis TechBio 7666.HKHong Kong$1.05B-64%+6,987%-367%n/an/an/a
Qingdao Huicheng Environmental Technology 300779.SZChina$1.08B-48%-13%5%69.5×n/an/a
Jubilant Ingrevia JUBLINGREA.NSIndia$1.00B-19%+15%10%21.6×28.0%+44.9%
Shanghai Emperor of Cleaning Hi-Tech 603200.SSChina$1.12B-24%+4%-8%n/an/an/a
CNSIG Inner Mongolia Chemical Industry 600328.SSChina$1.12B-36%-20%-7%n/an/an/a
Caregen 214370.KSSouth Korea$982M-74%-2%20%21.5×36.8%+3.8%
Jinan Acetate Chemical 4763.TWTaiwan$1.14B-5%-24%43%6.6×-20.2%+41.2%
Dalian Bio-Chem 603360.SSChina$971M-54%0%16%21.7×8.5%+18.4%
Hubei Jianghan New Materials 603281.SSChina$1.15B-38%+8%17%21.1×3.9%+6.3%
Raghav Productivity Enhancers RPEL.NSIndia$942M+109%+38%28%n/an/an/a
Lanxess LXS.DEGermany$1.19B-24%-4%0%n/a5.3%-1.5%
Jilin Chemical Fibre Stock 000420.SZChina$1.20B-34%+11%5%130.4×n/an/a
Jiangsu Zhengdan Chemical Industry 300641.SZChina$914M-29%-30%17%n/a7.1%+11.6%
Zhejiang Huangma Technology 603181.SSChina$891M-33%+7%17%13.8×n/an/a
Jiangsu Shuangxing Color Plastic New Materials 002585.SZChina$1.27B-10%-4%-4%57.9×21.0%+0.2%
Nippon Soda 4041.TJapan$1.29B+11%0%10%12.2×5.2%+1.8%
China Resources Chemical Innovative Materials 301090.SZChina$1.30B-33%+4%1%18.4×20.6%+1.1%
Guangzhou Sanfu Newmaterials Technology 688359.SSChina$832M-54%+8%-7%n/an/an/a
Rianlon 300596.SZChina$1.35B-15%+11%11%14.2×n/an/a
Hanchem 014680.KSSouth Korea$1.35B-49%+11%17%11.6×5.8%+7.4%

Questions

Who are Victrex's main competitors?
Named competitors: Solvay (private or unlisted), Evonik Industries (EVK.DE), Celanese (CE). The cockpit's measured peer set (industry) also includes Metis TechBio (7666.HK), Qingdao Huicheng Environmental Technology (300779.SZ), Jubilant Ingrevia (JUBLINGREA.NS), Shanghai Emperor of Cleaning Hi-Tech (603200.SS), CNSIG Inner Mongolia Chemical Industry (600328.SS), Caregen (214370.KS).
Is Victrex expensive compared with its peers?
On forward p/e it trades at 22.5× against a peer median of 21.1×, 4th most expensive of 14 in its peer set. For today's price to make sense, revenue must grow about 17% a year for seven years (Req g). Recent delivered growth is +2%, so the hurdle is +15 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Victrex stock performed?
Over six months to 18 Nov 2026 the shares returned +45.7% against -32.9% for the median peer; over one year +53.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.